Skip to main content

Dan Carson

Head of Investor Relations

Inmune Bio, Inc. (INMB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Inmune Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get INMB alerts

About Dan Carson

Dan Carson is recorded as Head of Investor Relations at Inmune Bio, Inc. (INMB). Dan Carson has spoken on 1 earnings call across 1 company, most recently for Inmune Bio, Inc. on November 5, 2026. Inmune Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inmune Bio, Inc. includes David J. Moss (CEO and Board Member), J. Kelly Ganjei (Chairman), Cory Ellspermann (Board Member) and 7 others.

Dan Carson on recent calls

“We thank you for joining us for the call for ImmuneBio's third quarter 2026 financial results. Presenting on today's call are David Moss, CEO and co-founder of ImmuneBio, Dr. Mark Lodell, Chief Scientific Officer and co-founder of ImmuneBio, and Corey Elsperman, ImmuneBio CFO.”
Head of Investor Relations, INmune Bio Inc. Announces Third Quarter 2026 Results and Provides Business Update ·

Affiliation history

Company network

Leadership on record at Inmune Bio, Inc.

Recent activity